{"id":"W2064927794","doi":"10.1097/coc.0b013e3181beac33","title":"A Multicenter Phase II Clinical Trial of Lapatinib (GW572016) in Hormonally Untreated Advanced Prostate Cancer","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Lapatinib; Medicine; Internal medicine; Prostate cancer; Rash; Oncology; Clinical endpoint; Cancer; Prostate-specific antigen; Breast cancer; Population; Phases of clinical research; Adverse effect; Clinical trial; Trastuzumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002332694,0.00192405,0.001443039,0.0004176198,0.0004770028,0.0009019308,0.0009200668,0.001360584,0.00506074],"category_scores_gemma":[0.0009930204,0.0006023254,0.0009993088,0.0004595098,0.001019473,0.0007566264,0.0004530494,0.003255227,0.0009458582],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007589759,"about_ca_system_score_gemma":0.002023967,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009210825,"about_ca_topic_score_gemma":0.001897906,"domain_scores_codex":[0.9993576,0.000384522,0.00002283366,0.0000866247,0.0000493169,0.00009903347],"domain_scores_gemma":[0.9991843,0.0001045574,0.0001451617,0.00005896485,0.00004721621,0.0004597685],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7900848,0.07880002,0.005465406,0.0007792028,0.001028744,0.0003747175,0.0002297543,0.002686766,0.03974107,0.0003587289,0.006230963,0.0742197],"study_design_scores_gemma":[0.7812954,0.2102657,0.004471267,0.00002048804,0.0001356811,0.0001846167,0.00002322288,0.0008259559,0.001724682,0.0001293187,0.0009059364,0.00001774747],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908034,0.001525527,0.0005949782,0.000610813,0.0001673023,0.003310507,0.0009735444,0.0001445738,0.00186938],"genre_scores_gemma":[0.9884477,0.001170357,0.001353177,0.0009675288,0.0002225685,0.003037579,0.002570692,0.0000357337,0.002194642],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00506074,"threshold_uncertainty_score":0.01692986,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09440197135542061,"score_gpt":0.5517576730823424,"score_spread":0.4573557017269217,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}